David Pacitti Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Pacitti APEN stock SEC Form 4 insiders trading

David has made over 1 trades of the Apollo Endosurgery Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 18,742 units of APEN stock worth 128,758$ on 19 May 2021.

The largest trade he's ever made was selling 18,742 units of Apollo Endosurgery Inc stock on 19 May 2021 worth over 128,758$. On average, David trades about 2,677 units every 0 days since 2017.

You can see the complete history of Mr. Pacitti stock trades at the bottom of the page.

David Pacitti biography

David C. Pacitti serves as Independent Director of the Company. Since November 2017, Mr. Pacitti has served as a member of our Board. Since 2015, Mr. Pacitti has served as the President of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers where he is responsible for leading the marketing, sales, service, and support functions in North America and Latin America, across the entire Healthineers portfolio, including medical imaging, laboratory diagnostics, therapy solutions, and services. From February 2006 to October 2015, Mr. Pacitti was with Abbott Vascular, a division of Abbott Laboratories, in a variety of commercial leadership roles. He serves as a member of the Board of Directors of the Advanced Medical Technology Association (AvaMed), the University City Science Center in Philadelphia, PA, the National Electrical Manufacturers Association (NEMA), and the Siemens Foundation. He is also a member of the CEO Council for Growth at the Chamber of Commerce for Greater Philadelphia, as well as the Children's Hospital of Philadelphia Corporate Council, the GAVS Customer Advisory Board, the Medical University of South Carolina (MUSC) President’s Advisory Council and the NextGen Advisory Board for the University of Missouri. Mr. Pacitti received a B.A. in Economics from Villanova University.

How old is David Pacitti?

David Pacitti is 54, he's been the Independent Director of Apollo Endosurgery Inc since 2017. There are 13 older and 5 younger executives at Apollo Endosurgery Inc. The oldest executive at Apollo Endosurgery Inc is Dr. Christopher J. Gostout, 70, who is the Co-Founder & Chief Medical Officer.

What's David Pacitti's mailing address?

David's mailing address filed with the SEC is 1120 S Capital of Texas Hwy #300, Austin, TX 78746, USA.

Insiders trading at Apollo Endosurgery Inc

Over the last 12 years, insiders at Apollo Endosurgery Inc have traded over 3,882,241$ worth of Apollo Endosurgery Inc stock and bought 10,717,094 units worth 45,588,363$ . The most active insiders traders include Holdings A/S Novo、Neil Gagnon、R Kent Jr Mc Gaughy. On average, Apollo Endosurgery Inc executives and independent directors trade stock every 41 days with the average trade being worth of 2,726,880$. The most recent stock trade was executed by Jeffrey G. Black on 25 February 2022, trading 40,000 units of APEN stock currently worth 229,200$.

What does Apollo Endosurgery Inc do?

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.

Complete history of Mr. Pacitti stock trades at Apollo Endosurgery Inc

Apollo Endosurgery Inc executives and stock owners

Apollo Endosurgery Inc executives and other stock owners filed with the SEC include:

• Christopher Gostout,
  Chief Medical Officer
• Todd Newton,
  Chief Executive Officer, Director
• John J. Molesphini,
  Exec. VP of Operations
• Bret Schwartzhoff,
  Vice President - North America Sales and Global Marketing
• Stefanie Cavanaugh,
  Chief Financial Officer, Secretary
• K. Todd Newton,
  Consultant
• Bret Schwartzhoff,
  VP, US Sales & Global Marketing
• Julie Shimer,
  Independent Director
• Bruce Robertson,
  Independent Director
• David Pacitti,
  Independent Director
• R. Kent McGaughy,
  Independent Director
• William McClellan,
  Independent Director
• John Barr,
  Independent Director
• Rick Anderson,
  Independent Director
• John Molesphini,
  Executive Vice President - Operations
• Dr. Christopher J. Gostout M.D.,
  Co-Founder & Chief Medical Officer
• Jeffrey G. Black,
  Chief Financial Officer
• Dr. Pankaj Jay Pasricha FACP, M.D., MBBS,
  Co-Founder
• Dr. Christopher J. Gostout,
  Co-Founder & Chief Medical Officer
• Sydney Chung M.D.,
  Co-Founder and Innovation Partner
• Dr. Peter Benjamin Cotton M.D.,
  Co-Founder and Innovation Partner
• Dr. Robert Hawes M.D.,
  Co-Founder and Innovation Partner
• Anthony Kalloo M.D.,
  Co-Founder and Innovation Partner
• Dr. Sergey Kantsevoy M.D.,
  Co-Founder and Innovation Partner
• Charles S. McKhann,
  CEO, Pres & Director
• Sciences Ii L Pptv Iv, L.P....,
  
• Ventures Llc Remeditex,
  10% owner
• Richard J Meelia,
  Director
• Dennis L. Mc Williams,
  President, CCO
• Ventures Endosurgery, Llc...,
  10% owner
• Holdings A/S Novo,
  10% owner
• John W Creecy,
  Director
• Charles Tribie,
  Executive V.P. of Operations
• Chas Mc Khann,
  President and CEO
• Sciences Ii L Pptv Iv, L.P....,
  
• Sciences Ii L Pptv Iv, L.P....,
  
• Capital, L.P. Stonepine,
  10% owner
• Sciences Ii L Pptv Special ...,
  
• Inc Cpmg,
  
• James W Jr Traweek,
  
• Neil Gagnon,
  10% owner
• Sciences Ii L Pptv Iv, L.P....,
  
• Inc Desai Antal Rohit Cpmg,
  
• Matthew S Crawford,
  10% owner
• Jeffrey G. Black,
  Chief Financial Officer
• Mike Gutteridge,
  VP, Int'l Sales and Marketing
• Sharon O'keefe,
  Director
• Jeannette Bankes,
  Director